Metalloproteases and inhibitors in arthritic diseases
- 1 December 2001
- journal article
- review article
- Published by Elsevier in Best Practice & Research Clinical Rheumatology
- Vol. 15 (5) , 805-829
- https://doi.org/10.1053/berh.2001.0195
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- Peroxisome proliferator-activated receptor gamma activators inhibit MMP-1 production in human synovial fibroblasts likely by reducing the binding of the activator protein 1Osteoarthritis and Cartilage, 2002
- Postnatal expression in hyaline cartilage of constitutively active human collagenase-3 (MMP-13) induces osteoarthritis in miceJournal of Clinical Investigation, 2001
- ICEBERGCell, 2000
- The Thrombospondin Motif of Aggrecanase-1 (ADAMTS-4) Is Critical for Aggrecan Substrate Recognition and CleavageJournal of Biological Chemistry, 2000
- Aggrecan degradation in human cartilage. Evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthritic, and rheumatoid joints.Journal of Clinical Investigation, 1997
- Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-αNature, 1997
- WANTED—THE COLLAGENASE RESPONSIBLE FOR THE DESTRUCTION OF THE COLLAGEN NETWORK IN HUMAN CARTILAGE!Rheumatology, 1996
- Regulating Expression of the Gene for Matrix Metalloproteinase-1 (Collagenase): Mechanisms that Control Enzyme Activity, Transcription, and mRNA StabilityCritical Reviews™ in Eukaryotic Gene Expression, 1996
- Furin-dependent intracellular activation of the human stromelysin-3 zymogenNature, 1995
- Dose-dependent suppression by the synthetic retinoid, 4-hydroxyphenyl retinamide, of streptococcal cell wall-induced arthritis in ratsInternational Journal of Immunopharmacology, 1985